Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth

Michael D. Nyquist(Fred Hutch Cancer Center), Peter S. Nelson(Fred Hutch Cancer Center)
Journal of Clinical Investigation
May 16, 2021
Cited by 40


Related Papers